影像學手段在結直腸癌術前評估中的應用_《華西醫學》

作者：

譚一非 ^1,2 , 張捷 ^1,2 , 汪曉東 ² ,  李立 ²

四川大學（成都，610041）1華西臨床醫學院MCQ團隊，2華西醫院胃腸外科中心;

關鍵詞：

結直腸癌術前評估影像學

DOI：

10.7507/1002-0179.20130155

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

對結直腸癌患者的術前病情評估對于進一步的治療和預后等具有重要作用，而近年來不斷發展的影像學手段對于病灶的檢測有較理想的效果，有利于制定最佳的治療方案，其中使用較普遍的有CT、MRI等。現就近年來影像學在結直腸癌術前評估中的應用現狀做一簡要綜述。

引用本文： 譚一非,張捷,汪曉東,李立. 影像學手段在結直腸癌術前評估中的應用. 華西醫學, 2013, 28(3): 481-484. doi: 10.7507/1002-0179.20130155 復制

1.	Luo MY, Liu L, Yan FH，et al. Preliminary study on MR colonography with air enema in detection of colorectal neoplasms[J]. Chi Med J, 2010, 123(18): 2527-2531.
2.	Burton S, Brown G, Bees N, et al. Accuracy of CT prediction of poor prognostic features in colonic cancer[J]. Br J Radiol, 2008, 81(961): 10-19.
3.	van der Bij GJ, Oosterling SJ, Beelen RHJ, et al. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer[J]. Annals Surg, 2009, 249(5): 727-734.
4.	Dennis A, Wicherts RJ, van Kessel CS, et al. Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards[J]. Eur J Radiol, 2011, 77(2): 305-311.
5.	Bader1 FG, Bouchard R, Lubienski A, et al. Fortschritte in der diagnostik anorektaler erkrankungen[J]. Chirurg, 2008, 79(5): 410-417.
6.	Smith NJ, Bees N, Barbachano Y, et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials[J]. Br J Cancer, 2007, 96(7): 1030-1036.
7.	Hennedige T, Teo L, Ang B, et al. Accuracy of preoperative CT for local staging in colorectal carcinomas[J]. Singa Med J, 2010, 51(6): 475-480.
8.	Grossmann I, Avenarius JKA, Mastboom WJB, et al. Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure[J]. Ann Surg Oncol, 2010, 17(8): 2045-2050.
9.	Koh JL, Yan TD, Glenn D. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis[J]. Ann Surg Oncol, 2009, 16(2): 327-333.
10.	Dirisamer A, Benjamin SH, Flöry D, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT[J]. Euro J Radiol, 2010, 73(2): 324-328.
11.	Orlacchio A, Schillaci O, N Fusco, et al. Role of PET/CT in the detection of liver metastases from colorectal cancer[J]. Radiologia Medica, 2009, 114(4): 571-585.
12.	Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting[J]. Radiology, 2005, 3(237): 893-904.
13.	Mulhall BP, Veerappan GR, Jackson JL, et al. Meta-analysis: computed tomographic Colonography[J]. Ann Intern Med, 2005, 142(8): 635-650.
14.	Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies[J]. Eur Radiol, 2010, 20(5): 1031-1046.
15.	Annemans L, Lencioni R, Warie H, et al. Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients[J]. Int J Colorectal Dis, 2008, 23(1): 77-83.
16.	Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging[J]. Br J Surg, 2003, 90(3): 355-364.
17.	Videhult P, Smedh K, Lundin K, et al. Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit[J]. Colorectal Dis, 2007, 9(5): 412-419.
18.	Stollfuss JC, Becker K, Sendler A, et al. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens[J]. Radiology, 2006, 1(241): 132-141.
19.	Iafrate F, Laghi A, Paolantonio P, et al. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings[J]. RadioGraphics, 2006, 3(26): 701-714.
20.	Yamada I,Okabe S, Enomoto M, et al. Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D constructive interference in steady-state MR imaging[J]. Radiology, 2008, 246(2): 444-453.
21.	Milot L, Guindi M, Gallinger S, et al. MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study[J]. Radiology, 2010, 254(3): 747-754.
22.	Thornton E, Morrin MM, Yee J. Current status of MR colonography[J]. Radiographics, 2010, 30(1): 201-218.
23.	Cantisani V, Ricci P, Erturk M, et al. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI[J]. Ultraschall Med, 2010, 31(5): 500-505.
24.	Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography[J]. Abdominal Imaging, 2007, 32(5): 624-634.
25.	Freimanl M, Edrei Y, Sela Y, et al. Classification of suspected liver metastases using fMRI images: a machine learning approach[J]. Medical Image Computing & Computer-Assisted Intervention, 2008, 11(1): 93-100.
26.	Sun L, Wu H, Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging[J]. WJG, 2008, 14(6): 853-863.
27.	Kapse N, Goh V. Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography[J]. Clin Colorectal Canc, 2009, 8(2): 77-87.
28.	Niekel MC, Bipat S, Stoker J, et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment[J]. Radiology, 2010, 257(3): 674-684.
29.	Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusionweighted sensitivity-encoding versus SPIO-enhanced MR imaging[J]. Radiology, 2006, 1(239): 122-130.
30.	Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination[J]. Eur Radiol, 2008, 18(5): 903-910.
31.	Mainenti PP, Mancini M, Mainolfi C, et al. Detection of colorectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticuloendothelial cell specific contrast agents[J]. Abdominal Imaging, 2010, 35(5): 511-521.
32.	Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection,1999[J]. Infect Cont Hosp Ep, 1999, 27(2): 97-134.
33.	Boyce JM. Antiseptic technology: access, affordability, and acceptance[J]. Emerg Infect Dis, 2001, 7(2): 231-233.
34.	Smith RL, Bohl JK, McElearney ST, et al. Wound infection after elective colorectal resection[J]. Ann Surg, 2004, 239(5): 599-607.
35.	Konishi T, Watanabe T, Kishimoto J, et al. Elective colon and rectal surgery differ in risk factors for wound infection: Results of prospective surveillance[J]. Ann Surg, 2006, 244(5): 758-763.
36.	Miki C, Inoue Y, Mohri Y, et al. Site-specific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery[J]. Dis Colon Rectum, 2006, 49(1): S45-S52.
37.	Miransky J, Ruo L, Nicoletta S, et al. Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection rates[J]. Dis Colon Rectum, 2001, 44(8): 1100-1105.
38.	Matsuda A, Matsutani T, Sasajima K, et al. Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery[J]. J Surg Res, 2009, 157(2): 227-234.
39.	汪曉東, 劉丹, 呂東昊, 等. 結直腸癌血清纖維蛋白原和炎性介質、腫瘤標志物的術前診斷價值[J]. 腫瘤防治研, 2010, 37(5) : 566-569.
40.	張瓊文, 呂東昊, 邰陽, 等. 64排多層螺旋CT和纖維蛋白原聯合評估結腸癌對手術方案選擇的影響[J]. 實用腫瘤雜志, 2010, 25(4) : 396-399.

1. 　Luo MY, Liu L, Yan FH，et al. Preliminary study on MR colonography with air enema in detection of colorectal neoplasms[J]. Chi Med J, 2010, 123(18): 2527-2531.
2. 　Burton S, Brown G, Bees N, et al. Accuracy of CT prediction of poor prognostic features in colonic cancer[J]. Br J Radiol, 2008, 81(961): 10-19.
3. 　van der Bij GJ, Oosterling SJ, Beelen RHJ, et al. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer[J]. Annals Surg, 2009, 249(5): 727-734.
4. 　Dennis A, Wicherts RJ, van Kessel CS, et al. Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards[J]. Eur J Radiol, 2011, 77(2): 305-311.
5. 　Bader1 FG, Bouchard R, Lubienski A, et al. Fortschritte in der diagnostik anorektaler erkrankungen[J]. Chirurg, 2008, 79(5): 410-417.
6. 　Smith NJ, Bees N, Barbachano Y, et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials[J]. Br J Cancer, 2007, 96(7): 1030-1036.
7. 　Hennedige T, Teo L, Ang B, et al. Accuracy of preoperative CT for local staging in colorectal carcinomas[J]. Singa Med J, 2010, 51(6): 475-480.
8. 　Grossmann I, Avenarius JKA, Mastboom WJB, et al. Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure[J]. Ann Surg Oncol, 2010, 17(8): 2045-2050.
9. 　Koh JL, Yan TD, Glenn D. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis[J]. Ann Surg Oncol, 2009, 16(2): 327-333.
10. 　Dirisamer A, Benjamin SH, Flöry D, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT[J]. Euro J Radiol, 2010, 73(2): 324-328.
11. 　Orlacchio A, Schillaci O, N Fusco, et al. Role of PET/CT in the detection of liver metastases from colorectal cancer[J]. Radiologia Medica, 2009, 114(4): 571-585.
12. 　Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting[J]. Radiology, 2005, 3(237): 893-904.
13. 　Mulhall BP, Veerappan GR, Jackson JL, et al. Meta-analysis: computed tomographic Colonography[J]. Ann Intern Med, 2005, 142(8): 635-650.
14. 　Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies[J]. Eur Radiol, 2010, 20(5): 1031-1046.
15. 　Annemans L, Lencioni R, Warie H, et al. Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients[J]. Int J Colorectal Dis, 2008, 23(1): 77-83.
16. 　Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging[J]. Br J Surg, 2003, 90(3): 355-364.
17. 　Videhult P, Smedh K, Lundin K, et al. Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit[J]. Colorectal Dis, 2007, 9(5): 412-419.
18. 　Stollfuss JC, Becker K, Sendler A, et al. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens[J]. Radiology, 2006, 1(241): 132-141.
19. 　Iafrate F, Laghi A, Paolantonio P, et al. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings[J]. RadioGraphics, 2006, 3(26): 701-714.
20. 　Yamada I,Okabe S, Enomoto M, et al. Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D constructive interference in steady-state MR imaging[J]. Radiology, 2008, 246(2): 444-453.
21. 　Milot L, Guindi M, Gallinger S, et al. MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study[J]. Radiology, 2010, 254(3): 747-754.
22. 　Thornton E, Morrin MM, Yee J. Current status of MR colonography[J]. Radiographics, 2010, 30(1): 201-218.
23. 　Cantisani V, Ricci P, Erturk M, et al. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI[J]. Ultraschall Med, 2010, 31(5): 500-505.
24. 　Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography[J]. Abdominal Imaging, 2007, 32(5): 624-634.
25. 　Freimanl M, Edrei Y, Sela Y, et al. Classification of suspected liver metastases using fMRI images: a machine learning approach[J]. Medical Image Computing & Computer-Assisted Intervention, 2008, 11(1): 93-100.
26. 　Sun L, Wu H, Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging[J]. WJG, 2008, 14(6): 853-863.
27. 　Kapse N, Goh V. Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography[J]. Clin Colorectal Canc, 2009, 8(2): 77-87.
28. 　Niekel MC, Bipat S, Stoker J, et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment[J]. Radiology, 2010, 257(3): 674-684.
29. 　Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusionweighted sensitivity-encoding versus SPIO-enhanced MR imaging[J]. Radiology, 2006, 1(239): 122-130.
30. 　Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination[J]. Eur Radiol, 2008, 18(5): 903-910.
31. 　Mainenti PP, Mancini M, Mainolfi C, et al. Detection of colorectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticuloendothelial cell specific contrast agents[J]. Abdominal Imaging, 2010, 35(5): 511-521.
32. 　Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection,1999[J]. Infect Cont Hosp Ep, 1999, 27(2): 97-134.
33. 　Boyce JM. Antiseptic technology: access, affordability, and acceptance[J]. Emerg Infect Dis, 2001, 7(2): 231-233.
34. 　Smith RL, Bohl JK, McElearney ST, et al. Wound infection after elective colorectal resection[J]. Ann Surg, 2004, 239(5): 599-607.
35. 　Konishi T, Watanabe T, Kishimoto J, et al. Elective colon and rectal surgery differ in risk factors for wound infection: Results of prospective surveillance[J]. Ann Surg, 2006, 244(5): 758-763.
36. 　Miki C, Inoue Y, Mohri Y, et al. Site-specific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery[J]. Dis Colon Rectum, 2006, 49(1): S45-S52.
37. 　Miransky J, Ruo L, Nicoletta S, et al. Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection rates[J]. Dis Colon Rectum, 2001, 44(8): 1100-1105.
38. 　Matsuda A, Matsutani T, Sasajima K, et al. Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery[J]. J Surg Res, 2009, 157(2): 227-234.
39. 　汪曉東, 劉丹, 呂東昊, 等. 結直腸癌血清纖維蛋白原和炎性介質、腫瘤標志物的術前診斷價值[J]. 腫瘤防治研, 2010, 37(5) : 566-569.
40. 　張瓊文, 呂東昊, 邰陽, 等. 64排多層螺旋CT和纖維蛋白原聯合評估結腸癌對手術方案選擇的影響[J]. 實用腫瘤雜志, 2010, 25(4) : 396-399.

上一篇
慢性乙型肝炎失代償期肝硬化的四種抗病毒藥物新進展

《華西醫學》

影像學手段在結直腸癌術前評估中的應用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

Format

Content

《華西醫學》

影像學手段在結直腸癌術前評估中的應用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料